secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001104659-23-045006
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Michael A. Kelly resigns; Board adopts 2023 Inducement Plan reserving 500,000 shares
--------------------------------------------------------------------------------

- Director Michael A. Kelly resigned effective April 7, 2023, not due to any disagreement with the Company.
- Terry Coelho appointed Chair of Audit Committee to fill vacancy; deemed audit committee financial expert.
- Board approved 2023 Inducement Plan reserving 500,000 shares of common stock for new employee inducement grants.
- Awards under the plan limited to employees commencing employment, per Nasdaq Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923045006/0001104659-23-045006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923045006/tm2312420d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-045006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer